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Abstract:  Past research has demonstrated that oestrogenic compounds produce strand 
breaks in the DNA of sperm and lymphocytes via reactive oxygen species (ROS). In the 
current investigation, sperm and lymphocytes were treated in vitro with oestrogenic 
compounds (diethylstilboestrol, progesterone, 17β-oestradiol, noradrenaline and 
triiodotyronine) and several aspects of DNA damage were investigated. Firstly, mediation 
of DNA damage by lipid peroxidation was investigated in the presence of BHA (a lipid 
peroxidation blocker). BHA reduced the DNA damage generated by 17β-oestradiol and 
diethylstilboestrol in a statistically significant manner. No effects were observed for sperm. 
Secondly, the presence of oxidized bases employing FPG and EndoIII were detected for 
lymphocytes and sperm in the negative control and after 24 h recovery in lymphocytes but 
not immediately after treatment for both cell types. The successful detection of oxidized 
bases in the negative control (untreated) of sperm provides an opportunity for its 
application in biomonitoring studies. DNA repair at 24 h after exposure was also studied. 
A nearly complete recovery to negative control levels was shown in lymphocytes 24 h 
recovery after oestrogenic exposure and this was statistically significant in all cases. Rapid 
rejoining of DNA, in a matter of hours, is a characteristic of DNA damaged by ROS. 
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1. Introduction 
Oestrogens play a key role in the development of feminine characteristics, control of reproductive 
cycles and pregnancy, and also have an influence on the skin, bone, the cardiovascular system and 
immunity [1]. In recent years, exposure to oestrogens and oestrogen-like compounds has been 
associated with the development of cancer and other effects [2]. A strong positive association between 
breast cancer risk and circulating levels of both oestrogens and androgens has been confirmed [3,4]. 
Epidemiological data implicate an imbalance of oestrogens and progestogens in the etiology of 
endometrial cancer [5]. In particular, the Women’s Health Initiative Study demonstrated that women 
receiving hormone replacement therapy (HRT), consisting of oestrogen plus progestin, have an 
increased risk of endometrial and invasive breast carcinoma [6]. Steroid hormones are involved in 
ovarian carcinogenesis [7,8] and a possible relationship exists between sex steroids and colon   
cancer [7,9]. Oestrogens have been implicated in the development of prostate cancer [10,11]. 
Moreover, they may also affect male fertility since xenoestrogens have been flagged as major culprits 
of male reproductive abnormalities [12]. The WHO-IARC classified oestrogens, steroidal and   
non-steroidal, as carcinogenic in humans [13], one of the main arguments being the fact that 
oestrogens not only can promote cancers but also may initiate mutations caused by certain oestrogen 
metabolites [14]. Their mechanisms of action are varied, including stimulation of cellular proliferation 
through receptor-mediated hormonal activity, increasing genetic mutation rates through cytochrome 
P450-mediated metabolic activation, and induction of aneuploidy [15]. 
Our group found evidence of the involvement of reactive oxygen species (ROS) in the DNA 
damage generated by phytoestrogens and oestrogenic compounds when investigated by means of the 
Comet assay [16,17]. Likewise, a later investigation stated that oxidative stress resulting from 
metabolic activation of carcinogenic oestrogens plays a critical role in oestrogen-induced 
carcinogenesis as confirmed in experiments in hamsters [18]. Oxidized metabolites from   
17β-oestradiol have been proved to elicit cytotoxicity in cultured human mammary epithelial cells, 
which was blocked by the antioxidant trolox [19]. The interaction of catechol-oestrogen and copper 
leads to the production of ROS which eventually cause DNA damage [20]. Recently, it has been 
reported that, in addition to the direct effect of oestrogens on mitochondria and the redox cycling of 
catechol-oestrogen, oestrogen-induced pro-inflammatory cytokines, such as interleukin-1β and tumor 
necrosis factor α, also generate reactive oxygen and nitrogen species (RO/NS) [21]. Endogenous   
non-steroidal hormones and related compounds such as neurotransmitters are present at low 
concentrations in the body, regulate physiological processes and have stimulatory effects on metabolic 
activities [22]. The thyroid hormones appear to regulate the duration of Sertoli cell proliferation, 
affecting adult Sertoli cell number and therefore the capacity to produce sperm [23]. In the thyroid, 
ROS and free radicals participate in physiological and pathological processes in the gland [24]. Also, 
during the normal catabolic pathway of oxidation of noradrenaline, ROS and H2O2 are produced [25] 
and this might be the cause for the genotoxicity reported for thyroid hormones and noradrenaline [26]. 
In the present investigation, we aimed to determine a number of characteristics linked to the 
presence of ROS. These were: (1) mediation of DNA damage through lipid peroxidation employing 
butylated hydroxyanisol (BHA); (2) detection of the presence of oxidized DNA bases employing 
specialized enzymes: formamidopyrimidine DNA Glycosylase (FPG) and endonuclease III (endo III); Int. J. Mol. Sci. 2011, 12                 
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and (3) DNA repair at a single time point of 24 h. The cells selected for this investigation are of 
relevance for different reasons. Lymphocytes are commonly employed as surrogate cells whilst sperm 
have been demonstrated to be affected by oestrogens. Furthermore, we investigated the described 
characteristics on five oestrogenic compounds (diethylstilboestrol (DES), progesterone (PG),   
17β-oestradiol, noradrenaline (NA) and triiodotyronine (T3)) providing a wide variety of functions and 
molecular structures to this study. We understand that the effects generated by oestrogens occur at 
lower concentrations. Physiological concentrations of these compounds are typically in the picoM to 
nM range: 17β-oestradiol (0.1 to 1.6 nM) [27], PG (30 to 600 nM) [28], NA (2 to 4 nM) [29] and  
T3 (1 to 3 nM) [30]. However, exposure occurs over longer periods of time and such conditions may 
become difficult to reproduce in vitro in a laboratory. Furthermore, we see a need to generate effects in 
order to be able to reveal the mechanisms underlying them. The concentrations selected have already 
been employed in previous investigations [16,17,22,26,31]. 
2. Results and Discussion 
2.1. Mediation of Lipid Peroxidation in the Generation of DNA Damage 
Lipid peroxidation appears to be a major source of endogenous DNA damage in humans that may 
contribute significantly to cancer and other genetic diseases linked to lifestyle and dietary factors [32]. 
ROS have been reported to impair membrane function [33]. This occurs in an initiation stage through 
the extraction of hydrogen from membrane lipids by ROS such as the hydroxyl radical (HO) [34]. 
Peroxyl radicals (ROO) are formed in the propagation stage, which after a cascade of reactions, ends 
up yielding deleterious effects to DNA. In sperm, oxidative stress is known to play a major role in the 
etiology of defective sperm function via mechanisms involving the induction of peroxidative damage 
to the plasma membrane [35]. 
Human PBL and sperm were co-incubated with oestrogenic compounds in the presence and absence 
of butylated hydroxyanisol (BHA). BHA is a well-known lipid peroxidation blocker used in the food 
industry [36]. This was in order to find out whether its presence modulated DNA damage by reducing 
or abolishing lipid peroxidation generated by oestrogens. By halting the lipid peroxidation, the end 
products are impeded in reacting with the DNA molecule. BHA at a concentration of 500 μM was 
selected on the basis of its DNA protective effects to a ROS inducing agent in CHO cells [37]. Reduction 
in genotoxic effects has also been observed in another investigation at this concentration [38]. 
In Figure 1a and b, the effect of BHA on the genotoxicity of oestrogenic compounds on 
lymphocytes and sperm is displayed. The negative control for lymphocytes and sperm in the absence 
of BHA provided an Olive tail moment value which was within the historical records in our laboratory 
as observed in publications by this group. BHA at a concentration of 500 μM exhibited a pro-oxidant 
effect which generated DNA damage in a statistically significant manner in both cell types. All 
oestrogenic compounds, the solvent (DMSO) and the positive control (H2O2) induced an increase in 
the values of Olive tail moment when compared to the negative control in both cell types. In 
lymphocytes (Figure 1a), BHA reduced the DNA damage generated by the oestrogenic compounds 
and H2O2 in all cases with the exception of DMSO. The reduction was statistically significant in some 
instances. By contrast, no reduction by BHA was observed at any treatment in sperm. Int. J. Mol. Sci. 2011, 12                 
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Figure 1. The Olive Tail Moment values fοr lymphocytes (a) and sperm (b) treated with 
oestrogenic compounds or Η2Ο2 for 30 min at 37 °C in the presence and absence of BHA 
(500  μM). The figures express the mean of the values obtained from 7 independent 
experiments (n = 7 different donors) in (a) and 5 independent experiments (n = 5 different 
donors) in (b). For (a) the average age was 27.57 ± 2.41 and for (b) the average age was 
30.80 ± 2.35. Normality of the data was evaluated with the Shapiro-Wilks test. Data were 
normally distributed. The Student’s T-test was applied. For statistical interpretation of the 
data, treatment in the absence of BHA was compared to treatment with the same compound 
with its presence. The levels of significance are included: n.s. not significant; *p ≤ 0.05; 
**p ≤ 0.01 and ***p ≤ 0.001. 
 
 
BHA on its own produced a pro-oxidant response in both lymphocytes and sperm. Genotoxic 
effects of BHA were already observed in gastrointestinal organs from mouse when measured with the 
Comet assay [39]. The presence of BHA reduced the levels of DNA damage in lymphocytes in all 
oestrogenic treatments and it abolished strand breaks against H2O2. Thus, this may indicate that DNA 
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damage induced by oestrogenic compounds in lymphocytes is mediated, at least partly, through lipid 
peroxidation. This could not be demonstrated for sperm since the responses obtained in the presence of 
BHA did not show a clear and common pattern. This poses an interesting outcome since sperm are 
known to possess a high content of PUFA. It might be possible that 500 µM BHA is not sufficient to 
counteract the genotoxic effects of the oestrogenic compounds in sperm. Further work is necessary to 
clarify the described effect in sperm. 
2.2. Detection of Oxidized Bases Induced by Oestrogenic Compounds in Lymphocytes and Sperm 
In addition to the endocrine-disrupting capability of oestrogenic compounds, further disruptive 
effects have been reported when oestrogenic compounds are metabolized. ROS and oestrogenic 
metabolites are produced which readily interact with the DNA structure and compromise its   
integrity [21]. In this regard, a report affirms that oestrogenic compounds can have a powerful impact 
on human spermatozoa via the induction of redox cycling behavior and the creation of adducts that 
cross-link DNA [40]. Therefore, we understand that there is evidence supporting that potentially 
oxidized bases are produced. With regard to the detection of oxidized bases, the Comet assay has been 
demonstrated to be the most sensitive and accurate technique for measurement of oxidized bases since 
other techniques have proved to be prone to generation of artifacts [41]. For this reason, Endo III and 
FPG were selected to identify oxidized bases in the Comet assay. The treatment period was also 
extended in order to increase the DNA damaging effects and; in turn, allow a more clear reflection of 
DNA repair in case it occurred. Cell viability was ensured after extended cell treatment. 
In Table 1, the data obtained for the detection of oxidized bases induced by oestrogenic treatment in 
lymphocytes as well as sperm are shown. The presence of enzymatic buffer in the negative control of 
both cell types provided values within historical records in our laboratory as observed in publications 
by this group. In the negative control corresponding to the experiment of lymphocytes without repair, 
the presence of the enzymes FPG and EndoIII generated a statistically significant increase in the Olive 
tail moment values. A small but not statistically significant increase was observed for the repair control 
in presence of FPG and EndoIII. No statistically significant increases were observed for the detection 
of oxidized bases after treatment with FPG or EndoIII in the presence or absence of repair. 
Nevertheless, detection of oxidized bases proved more consistent after repair since all treatments 
displayed values over their corresponding control levels. With regard to sperm, the presence of FPG 
and Endo III generated a statistically significant increase in the Olive tail moment of the negative 
control. No responses or even small reductions were produced in the oestrogenic treatments in the 
presence of FPG and EndoIII. Int. J. Mol. Sci. 2011, 12                 
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Table 1. Treatment of lymphocytes and sperm with 5 oestrogenic compounds, H2O2 and 
the negative control with and without the presence of FPG (1:3000) and Endo III (1:3000). 
The table expresses the mean of the values obtained from 7 independent experiments   
(n = 7 different donors) for lymphocytes and 5 independent experiments (n = 5 different 
donors) for sperm. For lymphocytes the average age was 27.57 ± 2.41. For sperm the 
average age was 30.8 ± 2.35. The data were evaluated for normality with the   
Shapiro-Wilks test. The data were normally distributed. ANOVA with Dunnet’s post-hoc 
was applied. For statistical interpretation of data, treatments with FPG or EndoIII were 
compared to the corresponding control. The levels of significance are included: n.s. not 
significant; *p ≤ 0.05; **p ≤ 0.01 and ***p ≤ 0.001. H2O2: hydrogen peroxide;   
DES: diethylstilboestrol; T3: triiodo-L-thyronine. 
Compound Treatment 
Lymphocytes Sperm 
120 min treatment 
120 min followed 
by 24 h repair  
(Olive tail 
moment) 
120 min  
(Olive tail 
moment) 
Control 
Buffer  3.65 ± 0.28  1.89 ± 0.32  2.94 ± 0.24 
FPG  6.29 ± 0.85 (**)  2.34 ± 0.72 (n.s.)  3.96 ± 0.34 (**) 
EndoIII  6.36 ± 0.55 (**)  2.08 ± 1.65 (n.s.)  4.12 ± 0.36 (**) 
Η2Ο2 
50 μΜ  17.13 ± 1.22   5.44 ± 1.36  4.98 ± 0.40 
FPG  16.72 ± 1.21 (n.s.)  6.51 ± 1.71 (n.s.)  4.91 ± 0.52 (n.s.) 
EndoIII  18.45 ± 1.16 (n.s.)  5.94 ± 1.80 (n.s.)  5.03 ± 0.47 (n.s.) 
17 β-oestradiol 
100 μΜ  8.01 ± 1.72  2.51 ± 0.70  5.52 ± 0.67 
FPG  8.89 ± 1.43 (n.s.)  2.97 ± 0.73 (n.s.)  6.24 ± 1.07 (n.s.) 
EndoIII  9.04 ±1.57 (n.s.)  3.01 ±0.65 (n.s.)  3.65 ± 0.50 (**) 
Progesterone 
100 μΜ  7.81 ± 1.34  2.76 ± 0.64  6.35 ± 0.57 
FPG  7.82 ± 1.23 (n.s.)  2.89 ± 0.63 (n.s.)  5.44 ± 0.65 (n.s.) 
EndoIII  7.04 ±1.09 (n.s.)  2.94 ±0.53 (n.s.)  5.82 ± 0.92 (n.s.) 
DES 
100 μM   22.62 ± 3.73  3.03 ± 0.86  6.55 ± 0.81 
FPG  24.90 ± 4.22 (n.s.)  4.80 ± 1.30 (n.s.)  5.48 ± 0.56 (n.s.) 
EndoIII  24.01 ± 3.24 (n.s.)  3.28 ± 1.56 (n.s.)  4.92 ± 0.75 (n.s.) 
T3 
46.9 μM   6.63 ± 1.03  2.02 ± 0.29  4.11 ± 1.12 
FPG  6.99 ± 1.31 (n.s.)  2.53 ± 0.33 (n.s.)  4.12 ± 0.43 (n.s.) 
EndoIII  6.09 ± 0.94 (n.s.)  2.28 ± 0.26 (n.s.)  4.45 ± 0.89 (n.s.) 
Noradrenaline 
100 μM  13.08 ± 2.91  2.72 ± 0.75  3.39 ± 0.70 
FPG  13.04 ± 1.30 (n.s.)  3.93 ± 1.23 (n.s.)  3.25 ± 0.77 (n.s.) 
EndoIII  13.50 ± 1.14 (n.s.)  2.78 ± 0.57 (n.s.)  2.79 ± 0.34 (n.s.) 
There was consistency amongst all oestrogenic compounds in the detection of oxidized bases after 
24 h repair in lymphocytes but they were not statistically significant. It is known that a critical step in 
the detection of oxidized bases after exposure to genotoxicants is the need for a recovery period in 
order to repair the strand breaks generated leaving the oxidized bases exposed which will be cleaved 
by FPG and EndoIII. The selection of a repair time which is too short results in confusion between 
strand breaks produced by the investigated genotoxicant and the ones originated by the enzymes (FPG Int. J. Mol. Sci. 2011, 12                 
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ad EndoIII). The fact that the DNA repair period reduced the Olive tail moment to nearly negative 
control levels (Figure 2) for all the treatments confirms that 24 h repair is an adequate recovery period. 
However, the possibility cannot be ruled out that a slightly longer repair, bringing Olive tail moment 
values down to negative control levels, might allow a more optimized detection of the oxidized bases. 
Two investigations have provided evidence of the capability of oestrogenic compounds to induce 
oxidized bases. Endo III, but not FPG, enhanced the DNA damaging effects of catechol in mouse 
lymphoma cells and extended term human lymphocytes [42]. FPG recognized oxidized bases for   
17β-oestradiol, 2-OH and 4-OH oestradiol in human breast cells MCF-7 [43]. The success of such 
investigations might be explained by a faster repair in cell lines compared to fresh lymphocytes. 
According to Collins, freshly isolated (as opposed to stimulated) lymphocytes rejoin strand breaks 
more slowly and this might reflect the need for lymphocytes to adapt to sudden exposure of oxygen in 
the atmosphere [44]. In this sense, the lack of repair in mature spermatozoa may be the reason for the 
absence of detection in treated sperm with high levels of DNA damage. 
The detection of oxidized bases in the negative controls of lymphocytes should not be surprising 
since there are large numbers of publications employing these two enzymes for monitoring purposes in 
lymphocytes [45–47]. Therefore, our results further support the validity of such approaches. To date, 
only one publication has measured oxidized bases in human testicular cells [48] and, to our knowledge, 
none has for ejaculated spermatozoa. The data displayed in the current investigation demonstrates the 
feasibility for detecting oxidized bases in ejaculated sperm when levels of DNA damage are low. 
These results might further stimulate research based on monitoring males for oxidized bases in ejaculated 
sperm and the correlation of such bases to environmental exposure and reproductive outcomes. 
2.3. DNA Repair after Oestrogenic Treatment 
A third mechanistic aspect investigated in the present study was DNA repair at 24 h after exposure 
to oestrogenic compounds as shown in Figure 2. It is widely known that strand breaks induced by ROS 
are quickly repaired. For instance, after 5 min repair time following treatment with H2O2 
approximately 30% of the DNA was repaired in well-nourished children and at 60 min this capacity 
increased to 82% [49]. The literature provides examples for other investigations with a similar 
outcome as it is the case of DNA repair in an in vitro study of nickel exposure [50] or repair in a cell 
lineage model of human proliferative breast disease [51]. To allow DNA repair to take place, thus 
reducing the levels of DNA strand breaks, an experimental design involving a recovery period was 
carried out in lymphocytes. This was not performed in sperm since mature spermatozoa are not able to 
repair DNA damage. The reason is due to a loss of cytoplasmic content during the maturation   
process [52–54].  
Hence, blood was obtained from 7 subjects and lymphocytes were isolated immediately before the 
performance of the experiment. The recovery time was 24 h and it was applied after 120 min treatment. 
These times were selected in order to maximize the effects. A clear reduction in the levels of DNA 
damage was demonstrated for all treatments and also included the negative control. Such an outcome 
may add further evidence supporting the generation of oxidative stress by oestrogenic compounds. Int. J. Mol. Sci. 2011, 12                 
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Figure 2. The Olive Tail Moment values fοr fresh lymphocytes treated with oestrogenic 
compounds or Η2Ο2 for 120 min and after 24 h repair in fresh medium. The mean of the 
values obtained from 7 independent experiments are shown (n = 7 different donors). 
Average age is 27.57 ± 2.41. Normality of the data was evaluated with the Shapiro-Wilks 
test. Data were normally distributed. The Student’s T-test was applied. For statistical 
interpretation of the data, no repair versus repair for each of the oestrogenic compounds 
was compared. The levels of significance are included: n.s. not significant; *p ≤ 0.05;  
**p ≤ 0.01 and ***p ≤ 0.001.  
 
3. Materials and Methods  
3.1. Human PBL Isolation 
Heparinized blood samples were obtained by venepuncture from 7 healthy male volunteers at the 
University of Bradford (UK) after signing a consent form. The procedures had been cleared by the 
University of Bradford’s Research Ethics sub-committee for Research involving Human subjects 
(Reference number: 0405/8). The average age was 27.57 ± 2.41 years old. All subjects were   
non-smokers and stated to be healthy. Lymphocytes were isolated from whole blood using 
Lymphoprep
® (Axis-Shield, Oslo, Norway) and the aliquots were stored in cryovials containing FBS 
with 1% DMSO for short-time storage at −80 °C. Freshly isolated lymphocytes were employed for the 
investigations detecting oxidized bases and DNA repair. 
3.2. Human Semen Evaluation 
Five subjects donated sperm. All semen samples were obtained with a signed consent form by the 
donor. The procedures had been cleared by the University of Bradford’s Research Ethics   
Sub-committee for Research involving Human subjects (Reference number: 0405/08). The average age 
was 30.8 ± 2.35 years old. All subjects were non-smokers and stated to be healthy. Semen samples 
were processed as described in the WHO criteria [13]. Semen was assessed shortly after ejaculation for 
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the following parameters: viscosity, morphology, motility, pH and concentration. All samples provided 
parameters considered as normal. After evaluation, the ejaculate was aliquoted in cryovials,   
flash-frozen in liquid nitrogen and stored at −80 °C. 
3.3. Comet Assay in Human PBL 
Treatments with the oestrogenic compounds were carried out in PBS at 37 °C and the time of 
exposure varied depending on the experimental design. For the studies on lipid peroxidation, a   
co-treatment of 30 min including the oestrogenic compound and BHA was carried out. For the 
detection of oxidized bases, the treatment was 120 min. In addition, a 24 h recovery period was 
allowed for characterization of DNA repair. The oestrogenic compounds (17β-oestradiol [CAS; 50-28-2], 
DES [CAS; 56-53-1], noradrenaline [CAS; 586-17-4], progesterone [CAS; 57-83-0], triiodothyronine 
(T3) [CAS; 5817-39-0], H2O2 [CAS; 7722-84-1] and BHA [CAS; 25013-16-5]) were purchased from 
Sigma. Dose response studies were carried out for all the compounds investigated (data not shown). 
Viability was evaluated with trypan blue (0.4%) (Sigma) and fluoresceine diacetate (Sigma) and it was 
greater than 75% for the concentrations selected for this investigation [55]. The Comet assay was 
performed as recommended in the IWGT Comet assay guidelines [56]. 
Oxidative DNA damage was evaluated using the bacterial enzymes FPG and EndoIII kindly 
provided by Prof. Andrew Collins (University of Oslo, Norway). The cell line lymphoblastoid TK6 
was employed to optimize the dilutions of FPG and endoIII to be used with sperm and lymphocytes. 
After overnight immersion in lysing buffer, the slides were rinsed and left covered with enzyme buffer 
containing a specific concentration of enzyme (1:3000) for both FPG and endoIII. The procedure was 
as described by Collins and co-workers [57,58]. After enzymatic incubation, the slides were rinsed 
again and placed in the electrophoresis tank. Thereafter, the procedure followed was as for the 
experiments in which no enzymes were used. 
3.4. Comet Assay with Human Sperm 
Sperm cryovials were quickly thawed. Treatment with oestrogenic compounds was carried out for 
30 min for the lipid peroxidation investigation and 120 min for the oxidized bases. The treatment was 
at 32 °C which is the optimum temperature for sperm. After treatment, Eppendorf
® tubes were gently 
centrifuged and the supernatant was removed. Treated cells were embedded in 2% LMP agarose and 
left to set on ice for 5 min. A third agarose layer (0.5%) LMP was included for those experiments not 
requiring enzymatic treatment. The slides were left for another 5 minutes on ice after which they were 
immersed in a Coplin jar containing 10 mM DTT (Sigma) for 60 min at 4 °C. Afterwards, slides were 
rinsed in PBS and newly immersed in a Coplin jar containing 0.05 mg/mL proteinase K (Roche) for  
60 min at 4 °C. If slides had to be treated with enzymes, an additional incubation with either FPG or 
EndoIII was carried out at this stage. Then, slides were rinsed again with excess electrophoresis buffer 
and placed in the electrophoresis tank. Unwinding lasted for 20 min followed by electrophoresis for 
another 20 min (25 V, 300 mA). Thereafter, the procedure carried out for the sperm was as previously 
described for lymphocytes. Int. J. Mol. Sci. 2011, 12                 
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3.5. Evaluation of the Data 
Experiments were carried out independently and in duplicate in all investigations. Each experiment 
corresponded to a different subject for all investigations. All values in this study are expressed as the 
mean ± S.E.M. from 5 (sperm) or 7 (lymphocytes) independent experiments. Slides were coded before 
scoring and fifty cells from each duplicate were scored per concentration per experiment. The 
parameter selected for the measurement of DNA damage in lymphocytes and sperm was Olive tail 
moment [59]. With regard to the investigation for detecting oxidized bases, the mean Comet value for 
the control (buffer) was subtracted from the mean score of the control with FPG or Endo III. The 
values obtained were considered as the increase due to the detection of oxidized bases in the control 
(background oxidized bases). Such values were subtracted from the values obtained after treatment 
with compounds (H2O2, 17β-oestradiol, progesterone, DES, T3 and noradrenaline) and FPG or Endo 
III. This was in order to only consider the oxidized bases generated by the oestrogenic treatment and 
not those present in the background. The statistics package used was Statistica 6.1 (Tulsa, OK, USA).  
P values of less than 5% were considered significant. 
4. Conclusion 
The present study reveals some possible mechanisms involved in the genotoxicity of oestrogenic 
compounds. It indicates that lipid peroxidation may contribute to the generation of strand breaks in the 
DNA of lymphocytes whilst the concentration of BHA selected may not be appropriate for sperm. 
Consistent detection of oxidized bases, though to a minor extent, was obtained in lymphocytes after 
DNA repair. This was not observed in sperm and it is likely to be due to their lack of DNA repair 
ability. However, oxidized bases were detected in the negative control and such a finding has a vast 
potential in biomonitoring studies. Lastly, very clear evidence of DNA repair was found after exposure 
to oestrogenic compounds in lymphocytes. This is characteristic of DNA damaged by ROS. This 
characterization was performed in lymphocytes which are extensively used as surrogate cells and 
sperm which is a target for oestrogenic compounds. Interestingly, DNA in somatic cells (lymphocytes) 
and sperm present major differences: DNA in sperm being half the content as well as more tightly 
packed. Despite such differences, strand breaks induced by five oestrogenic compounds were produced 
in both cell types for all the compounds selected. 
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